bucladesine has been researched along with Deficiency, Magnesium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Averdunk, R; Günther, T; Ostapowicz, B | 1 |
| Mochizuki, T; Okazaki, T; Sawada, H; Tashima, M; Uchino, H | 1 |
2 other study(ies) available for bucladesine and Deficiency, Magnesium
| Article | Year |
|---|---|
[The role of cyclic AMP and Ca in the altered permeability of tumour cells grown with a deficiency of Mg].
Topics: Animals; Biological Transport, Active; Bucladesine; Calcium; Cell Membrane Permeability; Cells, Cultured; Cyclic AMP; gamma-Aminobutyric Acid; In Vitro Techniques; Magnesium; Magnesium Deficiency; Methylglucosides; Ouabain; Potassium; Sarcoma, Yoshida; Sodium | 1975 |
Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Topics: Aclarubicin; Amanitins; Bucladesine; Calcitriol; Cell Differentiation; Cell Division; Cell Line; Cycloheximide; Dimethyl Sulfoxide; Drug Interactions; Humans; Leucine; Leukemia, Myeloid, Acute; Magnesium Deficiency; Naphthacenes; Oncogenes; Peptide Chain Elongation, Translational; Phenotype; RNA, Messenger; Tetradecanoylphorbol Acetate; Tretinoin | 1987 |